APA (7th ed.) Citation

PR, O., MI, H., A, M., M, M., MD, D. V., R, F., . . . LA, T. (2006). Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics. Diabetes research and clinical practice, 71(3), 320. https://doi.org/10.1016/j.diabres.2005.07.009

Chicago Style (17th ed.) Citation

PR, Olmos, et al. "Nicotinamide Protected First-phase Insulin Response (FPIR) and Prevented Clinical Disease in First-degree Relatives of Type-1 Diabetics." Diabetes Research and Clinical Practice 71, no. 3 (2006): 320. https://doi.org/10.1016/j.diabres.2005.07.009.

MLA (9th ed.) Citation

PR, Olmos, et al. "Nicotinamide Protected First-phase Insulin Response (FPIR) and Prevented Clinical Disease in First-degree Relatives of Type-1 Diabetics." Diabetes Research and Clinical Practice, vol. 71, no. 3, 2006, p. 320, https://doi.org/10.1016/j.diabres.2005.07.009.